Christophe Borg

Presentation(s):

• SO-20: Stanniocalcin 1 (STC1) in patients with refractory colorectal cancer (CRC) treated with regorafenib: An exploratory analysis of the CORRECT trial

  Friday, July 1, 2022
  08:50 – 08:58

• Regorafenib + IO agents: Why does site matter?

  Saturday, July 2, 2022
  13:45 – 14:00